Kirn, David H.

Targeted and armed oncolytic poxviruses: a novel multi-mechanistic therapeutic class for cancer

Kirn, D. H., & Thorne, S. H. (2009) · Nature Reviews Cancer

Virus-based gene therapy researchPoxvirus research and outbreaks

Cited by 402

Thrombotic microangiopathy following systemic AAV administration is dependent on anti-capsid antibodies

Salabarria, S. M., Corti, M., Coleman, K. E., Wichman, M. B., Berthy, J. A., D’Souza, P., Tifft, C. J., Herzog, R. W., Elder, M. E., Shoemaker, L. R., et al. (2024) · Journal of Clinical Investigation

Virus-based gene therapy researchComplement system in diseases

Cited by 159

Design and Characterization of a Novel Intravitreal Dual-Transgene Genetic Medicine for Neovascular Retinopathies

Calton, M. A., Croze, R. H., Burns, C., Beliakoff, G., Vazin, T., Szymanski, P., Schmitt, C., Klein, A., Leong, M., Quezada, M., et al. (2024) · Investigative Ophthalmology & Visual Science

Virus-based gene therapy researchRetinal Development and Disorders

Cited by 21

Directed Evolution of AAV Targeting Primate Retina by Intravitreal Injection Identifies R100, a Variant Demonstrating Robust Gene Delivery and Therapeutic Efficacy in Non-Human Primates

Kotterman, M., Beliakoff, G., Croze, R., Vazin, T., Schmitt, C., Szymanski, P., Leong, M., Quezada, M., Holt, J., Barglow, K., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory)

Virus-based gene therapy researchRetinal Development and Disorders

Cited by 20